Kefeng Xiao

613 citations
22 papers · 381 indexed · h-index 11
Topics
Prostate Cancer Treatment and Research (8 papers)Prostate Cancer Diagnosis and Treatment (5 papers)Bladder and Urothelial Cancer Treatments (4 papers)
Partner nations
ChinaUnited StatesSweden

In The Last Decade

Kefeng Xiao

22 papers receiving 376 citations

Peers

Kefeng Xiao
Comparison fields: 5 of 69
  • Molecular Biology 197
  • Pulmonary and Respiratory Medicine 160
  • Cancer Research 141
  • Oncology 82
  • Pediatrics, Perinatology and Child Health 41
Replace Fucai Tang with:
Fucai Tang China
Tomoyuki Imai Japan
Marc Gigante France
E. Streeter United Kingdom
Hayriye Tatlı Doğan Türkiye
Christoph von Klot Germany
Shuqiu Chen China
Florian Klinglmüller Austria
Nozomi Shinohara Japan
Ana Teresa Martins Portugal
Kefeng Xiao relative to Fucai Tang China Fucai Tang's profile →
Citations per field
00.5×
Fucai Tang · 1×
Citations per year

Countries citing papers authored by Kefeng Xiao

Since Specialization
Citations

This map shows the geographic impact of Kefeng Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Xiao more than expected).

Fields of papers citing papers by Kefeng Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kefeng Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Xiao. The network helps show where Kefeng Xiao may publish in the future.

Co-authorship network of co-authors of Kefeng Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Kefeng Xiao. A scholar is included among the top collaborators of Kefeng Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kefeng Xiao. Kefeng Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 1
3 4
4 11
5 2
6 2
7 2
8 61
9 2
10 27
11 12
12 15
13 53
14 26
15 35
16 47
17 1
18 10
19 8
20 8

About Kefeng Xiao

Kefeng Xiao is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 22 papers that have together received 381 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). The work is most often cited by research in Cancer Research (141 citations), Pulmonary and Respiratory Medicine (160 citations) and Oncology (82 citations). Kefeng Xiao has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Jinan Guo, Chang Zou, Xueqi Zhang, Yeqing Yuan, Jing Xie, Zaishang Li, Zhiqiang Cheng, Pan Zhao, Jianhong Wang and Yanfeng Liu. Their work appears in journals such as The Journal of Urology, Molecular Cancer and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026